Callan Family Office’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Sell
10,089
-10,800
-52% -$2.41M 0.04% 354
2026
Q1
$4.72M Buy
20,889
+167
+0.8% +$38.2K 0.11% 202
2025
Q4
$4.04M Buy
20,722
+5,870
+40% +$1.15M 0.09% 218
2025
Q3
$2.95M Sell
14,852
-827
-5% -$173K 0.09% 220
2025
Q2
$3.44M Buy
15,679
+6,621
+73% +$1.34M 0.11% 201
2025
Q1
$1.81M Sell
9,058
-2,811
-24% -$569K 0.14% 137
2024
Q4
$2.53M Buy
+11,869
New +$2.48M 0.16% 123

Other funds holding HON

Callan Family Office's HON Position: Q2 2026 in Review

Callan Family Office reduced its Honeywell (HON) stake by 52% in Q2 2026, selling an estimated $2.41M and leaving 10,089 shares worth $2.26M. The position accounts for 0.04% of the portfolio, ranked #354.

Callan Family Office first reported a position in HON in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.72M in Q1 2026. 2,179 funds tracked by Wall St. Rank hold HON as of Q2 2026.

  • Callan Family Office held 10,089 shares of Honeywell worth $2.26M as of Q2 2026.
  • Callan Family Office sold 10,800 Honeywell shares in Q2 2026, an estimated $2.41M.
  • Honeywell made up 0.04% of Callan Family Office's portfolio in Q2 2026, its #354 holding.
  • Callan Family Office first reported a position in Honeywell in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Honeywell position peaked at $4.72M in Q1 2026.
  • 2,179 funds tracked by Wall St. Rank held Honeywell as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.